EUVIMEDEUVIMED entdecken
Crossref

Exploring the GDP binding to KRas WT, G12C, G12D, G12R, and G12V and bound with MRTX1133 using steered molecular dynamics

Abdulaziz Alamri, Showkat Ahmad Mir, Shahnawaz Khan, Irshad Ahmad, Jamoliddin Razzokov, Binata Nayak

European Biophysics Journal · 2026

DOI: 10.1007/s00249-026-01817-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Biophysics Journal, 2026. Verfasst von Abdulaziz Alamri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Sciences, King Saud University, Riyadh, 1145, Saudi Arabia. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Guanosine Diphosphate, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 23 Literaturangaben. Gefördert von: Researcher Supporting grant, Agency for Innovative Development of the Republic of Uzbekistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oncogenic KRas protein is a crucial therapeutic target for cancer, but the efficacy of inhibitors against its variants remains complex. Using steered molecular simulations we quantified the binding free energies (ΔGbind) of GDP to wild-type (WT) KRas and its key oncogenic mutants G12C, G12D, G12R, and G12V, with and without MRTX1133 a potential inhibitor of the KRas G12D variant. In this study we highlighted the cooperative effect of GDP on holo KRas and KRas-bound MRTX1133, including variants. In comparison to the WT’s baseline of KRas, the ΔGbind of GDP was found to be -49 ± 3.3 kJ/mol. The ΔGbind increases significantly against variants G12C, G12D, G12R, and G12V, ranging from − 99.2 ± 12.3 to -154.8 ± 5.05 kJ/mol), respectively, resulting in higher effectiveness two to three times more against halo KRas variants. Furthermore, the ΔGbind of GDP against WT, KRas complexed with MRTX1133, was found to be -100.5 kJ/mol, whereas the ΔGbind against variants G12C, G12D, G12R, and G12V ranges from 110.6 ± 14.4 to -113.2 ± 2.7 kJ/mol, respectively. The binding affinities confirmed that GDP is a fundamental driver of oncogenicity. This reveals a significant cooperative effect where the presence of MRTX1133 paradoxically strengthened subsequent GDP binding in all systems. These findings provide a molecular-level explanation for the aggressiveness of KRas mutants. More importantly, this study reveals a potentially counterproductive mechanism for the G12R and G12V variants, where the inhibitor may inadvertently hyper-stabilize the active oncogenic state. This study highlights the critical need for mutation-specific strategies in designing Pan-KRas inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationGuanosine DiphosphateProto-Oncogene Proteins p21(ras)Protein BindingMutationThermodynamicsHumansHeterocyclic Compounds, 2-RingNaphthalenes

Stichwörter der Autor:innen

GDP bindingKRas WT & variants MRTX1133Steered molecular dynamics simulations

Substanzen

Guanosine DiphosphateProto-Oncogene Proteins p21(ras)KRAS protein, humanKRASG12D inhibitor MRTX1133Heterocyclic Compounds, 2-RingNaphthalenes

Autor:innen und Institutionen

  • Department of Biochemistry, College of Sciences, King Saud University, Riyadh, 1145, Saudi Arabia.
  • School of Life Sciences, Sambalpur University, Jyotivihar, Burla, Sambalpur, 768019, Odisha, India. showkat@suniv.ac.in.
  • Department of Biochemistry, College of Sciences, King Saud University, Riyadh, 1145, Saudi Arabia. moskhan@ksu.edu.sa.
  • Department of Biochemistry and Structural Biology, School of Medicine, UTHEALTH Science Center, San Antonio, TX, 78229-3900, USA.
  • Institute of Fundamental and Applied Research, National Research University TIIAME, Kori Niyoziy 39, Tashkent, 100000, Uzbekistan.
  • Department of Inorganic, Physical and Colloidal Chemistry, Faculty of Pharmacy, Tashkent Pharmaceutical Institute, Tashkent, 100015, Uzbekistan.

Förderung

  • Researcher Supporting grant
  • Agency for Innovative Development of the Republic of Uzbekistan

Zitieren

APA

Alamri, A., Mir, S. A., Khan, S., Ahmad, I., Razzokov, J., & Nayak, B. (2026). Exploring the GDP binding to KRas WT, G12C, G12D, G12R, and G12V and bound with MRTX1133 using steered molecular dynamics. European Biophysics Journal. https://doi.org/10.1007/s00249-026-01817-8

Vancouver

Alamri A, Mir SA, Khan S, Ahmad I, Razzokov J, Nayak B. Exploring the GDP binding to KRas WT, G12C, G12D, G12R, and G12V and bound with MRTX1133 using steered molecular dynamics. European Biophysics Journal. 2026. doi:10.1007/s00249-026-01817-8

BibTeX
@article{Alamri2026,
  author = {Alamri, Abdulaziz and Mir, Showkat Ahmad and Khan, Shahnawaz and Ahmad, Irshad and Razzokov, Jamoliddin and Nayak, Binata},
  title = {Exploring the GDP binding to KRas WT, G12C, G12D, G12R, and G12V and bound with MRTX1133 using steered molecular dynamics},
  journal = {European Biophysics Journal},
  year = {2026},
  doi = {10.1007/s00249-026-01817-8}
}
Kostenlos starten →